Profile
Carole Monterrat worked as the Chief Financial Officer at Sopartec SA from 2014 to 2018 and as the Vice President-Resources at PROMETHERA Biosciences SA from 2009 to 2014.
She holds a doctorate from Université de Bordeaux and an MBA from Université Catholique de Louvain, which she received in 2008.
Former positions of Carole Monterrat
| Companies | Position | End |
|---|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Director of Finance/CFO | 01/09/2018 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Corporate Officer/Principal | 01/03/2014 |
Training of Carole Monterrat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Finance |
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
- Stock Market
- Insiders
- Carole Monterrat
















